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Genetic polymorphisms and 
their association with brain 
and behavioural measures in 
heterogeneous stock mice
Magdalena Janecka1, Sarah J. Marzi1, Michael J. Parsons1,2, Lin Liu1, Jose L. Paya-Cano1, 
Rebecca G. Smith1, Cathy Fernandes1,* & Leonard C. Schalkwyk1,3,*
Although the search for quantitative trait loci for behaviour remains a considerable challenge, the 
complicated genetic architecture of quantitative traits is beginning to be understood. The current 
project utilised heterogeneous stock (HS) male mice (n = 580) to investigate the genetic basis for brain 
weights, activity, anxiety and cognitive phenotypes. We identified 126 single nucleotide polymorphisms 
(SNPs) in genes involved in regulation of neurotransmitter systems, nerve growth/death and gene 
expression, and subsequently investigated their associations with changes in behaviour and/or brain 
weights in our sample. We found significant associations between four SNP-phenotype pairs, after 
controlling for multiple testing. Specificity protein 2 (Sp2, rs3708840), tryptophan hydroxylase 1 (Tph1, 
rs262731280) and serotonin receptor 3A (Htr3a, rs50670893) were associated with activity/anxiety 
behaviours, and microtubule-associated protein 2 (Map2, rs13475902) was associated with cognitive 
performance. All these genes except for Tph1 were expressed in the brain above the array median, and 
remained significantly associated with relevant behaviours after controlling for the family structure. 
Additionally, we found evidence for a correlation between Htr3a expression and activity. We discuss 
our findings in the light of the advantages and limitations of currently available mouse genetic tools, 
suggesting further directions for association studies in rodents.
Quantitative traits (QT) are phenotypes that vary continuously in the population, likely due to their polygenic 
background. Examples of QTs include anthropometric measures (height), behaviour (neuroticism) and physio-
logical profiles (alcohol metabolism). Genome-wide research in humans and animals has long tried to identify 
QT loci (QTLs), chromosomal regions where allelic variation is associated with a measurable change in those 
traits1,2. Nevertheless, this remains a challenge due to the highly complicated genetic architecture of QTs, with 
phenomena like pleiotropy, polygenicity, gene-gene and gene-environment interactions most likely involved.
Investigating the genetic underpinnings of behaviour and psychiatric disorders is further complicated by the 
phenotypic complexity of these measures. The currently prevailing view is that most of them are multi-faceted 
constructs, fractionable into a number of molecular and behavioural processes (endophenotypes)3,4. Importantly, 
different disorders often involve overlapping endophenotypes – a phenomenon, which explains common genetic 
variation between them, rendering the search for disorder-specific loci problematic. For this reason, investigating 
the endophenotypes’, rather than the disorders’ QTLs may be more attainable.
The relative simplicity of these measures allows for employing model organisms in attempts to understand the 
genetic basis of behaviour. Mouse models have been highly instrumental in behavioural genetic research, offering 
scientists a variety of different tools (e.g. knock-out models, congenic strains, outbred populations) that allow for 
fine dissection of the complex psychiatric disease phenotypes. In our study we used heterogeneous stock (HS) 
mice, an outbred population derived from eight inbred strains: A/J, AKR, BALB/c, C3H/2, C57BL, DBA/2, Is/Bi 
and RIII5 that have been intercrossed for over 70 generations, with pseudo-random breeding protocols to achieve 
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high levels of recombination6. The HS mice have a number of advantages in genetic research, including some the 
highest resolution mapping of QTLs (of up to 1Mb7) offered by mouse genetic models8,9.
Using HS mice we aimed to identify the genetic underpinnings of behavioural domains affected in a num-
ber of psychiatric disorders, namely anxiety, activity and cognitive phenotypes. We investigated the association 
between behavioural tests that provide indices of these functions and a series of single nucleotide polymorphisms 
(SNPs) in candidate genes involved in major neurotransmitter systems (glutamate (Glu), serotonin (5HT), 
dopamine (DA), acetylcholine (Ach), GABA, noradrenaline (NA), and the endocannabinoid system), neuronal 
growth/death and gene expression (Table S1). We also tested if genetic polymorphisms in these loci could predict 
variance in the brain measures (cerebellum, hippocampus, whole brain weights) of these animals. Finally, all sig-
nificant SNP-phenotype associations were supplemented with expression data analysis from the same individuals. 
Although the list of genes we investigated was by no means exhaustive, nominating a more limited number of loci 
from across a range of biological pathways offered us a better scope to identify the molecular background of the 
phenotypes we were interested in than narrower, more in-depth search.
Together with our findings, we discuss the validity of HS as a tool for genetic research, and suggest further 
directions for genetic association studies in mice.
Results
Allele frequency. There were 126 SNPs in our original set of loci within genes of potential behavioural rele-
vance (synaptic transmission, nerve growth/death, gene expression). Of these, 94 SNPs were in Hardy-Weinberg 
equilibrium (HWE) with a p > 0.05 cut-off, and further 10 reasonably close to it, warranting their inclusion in the 
analyses. Within the final sample of 104 SNPs, a substantial number of SNPs had very low minor allele frequen-
cies (MAF < 0.125). Table S2 presents the frequencies of minor allele homozygotes and heterozygotes for all the 
SNPs genotyped.
Interrogation of the mouse SNP database published by the Wellcome Trust Sanger Consortium10 showed 
that in the HS founders, there were 2,724 SNPs annotated as exonic, out of which 317 were highly polymorphic 
between the HS founding strains.
Data properties. Descriptive statistics for the behavioural and brain data are presented in Tables S3 and S4, 
respectively. The Shapiro-Wilk tests indicated that only measures of mean speed upon transfer to home cage were 
normally distributed in the HS sample (W = 0.992, p = 0.061; for other behavioural measures: 0.468 < W < 0.985; 
2.2E-16 < p < 2.5E-5; brain measures: 0.602 < W < 0.978; 2.2E-16 < p < 6.0E-6). However, visual inspection sug-
gested that the distribution in most of the measures approximated normal; the exceptions were the measures 
representing latencies in the Puzzle Box and anxiety indices, where the distributions were censored (variables 
marked in the Table S3 with an (*)).
Spearman rank correlation confirmed that most measures within each behavioural test, except for the Morris 
Water Maze (MWM) measures, were significantly correlated with each other (pmean = 0.040, pMWM = 0.495), and 
that this correlation was moderate (ρmean = 0.323, ρMWM = 0.032; calculations performed using absolute rho val-
ues). Given the degree of correlation within, but not between tests (ρmean = 0.134), the number of behavioural 
tests, rather than total measures was used when correcting for multiple testing. Due to the lack of correlation 
between MWM measures, they were treated as separate tests in the False Discovery Rate protocol used to control 
for multiple testing.
All brain weights were shown to be significantly and positively correlated with each other and body weight 
(0.103 < ρ < 0.421). The exception was hippocampal weight, which was not significantly correlated with body 
weight (Table S5, Figure S3).
Analysis of variance revealed that most of the measures, of both brain and behaviour, showed significant 
batch effects (Fmean = 20.712, pmean = 0.159); this justified our approach of regressing the batch effects out of all 
our analyses.
Effects of genetic polymorphisms on behaviour and brain measures.  Out of all of the SNP-behaviour 
pairs tested, only associations between (i) Sp2 (rs3708840) and total duration in the centre area of the elevated 
plus maze, (ii, iii) Tph1 (rs262731280) and number of transitions between light and dark chambers, and time 
spent in the light chamber remained significant after multiple-testing correction at q = 0.01. Additionally, (iv) 
Map2 (rs13475902) and mean latency to removing the plug in the puzzle box, and (v) Htr3a (rs50670893) and 
peripheral activity in the open field were significant at q = 0.05 (Fig. 1, Table 1). After also controlling for the 
family structure, all but (ii) were significant at q = 0.05, and all but (ii) and (iii) at q = 0.01. All SNP-brain measure 
associations were below the required threshold.
The top 100 SNP-phenotype associations (p < 0.02) analysed for the possibility of gene-behavioural domain 
clusters revealed significant enrichment (Chi2(14) = 37.693, p = 6.0E-4; Table 2) in some functional groups (full 
list of these associations in Table S6).
In the Northport Stock (Wellcome Trust Centre for Human Genetics, http://mus.well.ox.ac.uk/mouse/
HS/), there was a QTL for distance travelled in the closed arms of the elevated plus maze at ch11: 92,322,571–
96,137,510, very close to our significant Sp2 region (ch11: 96,953,340–96,982,959). There was also a region asso-
ciated with activity in the open field arena on the Htr3a gene, as well as further upstream on chromosome 9. The 
Tph1 region did not harbour any anxiety-related QTLs, and there were no cognition-related phenotypes available 
for the Northport Stock, precluding validation of our Map2 results in an independent dataset.
Associations between gene expression and behaviour. Gene expression profiles of the cortex tis-
sue were performed for a subset (n = 265) of mice. For the genes containing polymorphisms associated with 
behavioural measures, Sp2 (6.131), Map2 (11.389) and Htr3a (7.323) showed expression above the array median 
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(5.996), while Tph1 (3.900) expression was below the median. Testing for associations between gene expression 
and the corresponding behavioural measures revealed that only Htr3a expression was significantly associated 
with peripheral activity in the open field (p = 0.011, Table S7), where higher Htr3a expression was linked to a 
shorter distance travelled in the outer zone of the open field (Fig. S4). Association between Map2 expression and 
plug removal was also near-significant (p = 0.077, Table S7), with higher gene expression predictive of shorter 
latency to perform the task. Given expression analyses was performed only on the SNP-phenotype pairs that 
remained significant in the genetic association testing after the FDR correction (5 pairs), p-values presented in 
this section were not corrected for multiple testing.
Figure 1. SNP-behaviour associations that remained significant after multiple testing correction. Each 
graph presents the mean values for the given phenotype, broken down by genotype, with error bars showing 
the SE. The panels represent the associations between (A) Sp2 (rs3708840) and total duration in the centre area 
of the elevated plus maze, (B) Tph1 (rs262731280) and time spent in the light chamber during the Light/dark 
exploration test, (C) Tph1 (rs262731280) and number of transitions between light and dark chambers during 
the Light/dark exploration test, (D) Map2 (rs13475902) and mean latency to remove the plug in the Puzzle box 
test, and (E) Htr3a (rs50670893) and total distance travelled in the outer zone of the open field. SE. The p-values 
represent the significance level of the association, also indicating which model was used in the test (BCT – linear 
model with Box-Cox transformed values; S – Cox proportional hazards survival model).
Gene SNP rs Phenotype
p-value
Model Behavioural domain FunctionNo-FS FS
Sp2 rs3708840 Elevated plus maze, total duration in the centre area 9.23e-7** 2.26e-6** BCT Anxiety/activity phenotypes Transcription factor
Tph1 rs262731280 Light/dark exploration test, Time spent in the light chamber 5.16e-6** 9.03e-4* S Anxiety/activity phenotypes 5HT signalling
Tph1 rs262731280
Light/dark exploration test, 
number of transitions between 
light and dark chambers
1.07e-5** 2.18e-3 S Anxiety/activity phenotypes 5HT signalling
Map2 rs13475902 Puzzle box, Plug (mean latency) 3.71e-4* 1.56e-2** S Cognitive phenotypes nerve growth/death
Htr3a rs50670893 Open field, total distance travelled in the outer zone 5.98e-4* 5.40e-2** BCT Anxiety/activity phenotypes 5HT signalling
Table 1.  SNP-behaviour associations significant after correcting for multiple testing. As indicated in the 
model column, the tests were run either as a linear model, with Box-Cox transformed data (BCT), or, if the 
measures displayed censored distribution as a Cox proportional hazards survival model (S); the effects of batch 
were regressed out in all cases. P-values from models that did (FS) and did not (no-FS) control for the family 
structure are presented. **SNPs are significant after FDR correction at q = 0.01, *at q = 0.05.
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Discussion
Genetic effects on behaviour and brain measures in HS mice.  Figure 2 shows the full summary of 
our results from the genetic association and brain expression analyses. We observed associations between loci 
on Sp2 (rs3708840) and Tph1 (rs262731280) and anxiety phenotype measures, which remained significant after 
multiple testing correction at q = 0.01. In both cases the polymorphism was associated with a missense mutation 
predicting change of amino acids with different hydropathy indices, likely to affect functioning of the protein they 
form, and its interactions with other molecules. At a lower significance level (q = 0.05) we also noted associations 
between a SNP on Map2 (rs13475902) and latency to remove a cardboard plug, which blocked the underpass in 
the puzzle box test, as well as between a SNP on Htr3a (rs50670893) and distance travelled in the outer zone of 
the open field. Expression analysis revealed that all of these genes, with the exception of Tph1, were detected in 
the brain (expression levels above the array median). Expression levels of Htr3a were also significantly associ-
ated with the open field behaviour, with an indication of similar effects between Map2 expression and latency to 
remove the plug in the puzzle box.
Comparison of our results with the Wellcome Trust resource11 provided support for some (Sp2, Htr3a), but 
not all of these associations. As mentioned above, this could be expected given only partially overlapping sets of 
inbred strain founders of the HS Northport and Boulder stocks. The other important difference between ours and 
Wellcome Trust dataset was the number of mice geno-/phenotyped – although Valdar et al.11 analysed higher 
number of individuals, these included multiple mice from the same litters, likely resulting in higher family struc-
ture (and lower genetic variance) than in our set. The level of genetic and phenotypic detail provided by these 
datasets also differs – we conducted more behavioural assessments than available in the Wellcome Trust resource; 
on the other hand, the latter dataset offers genome-wide genetic information, in contrast to candidate-gene anal-
ysis performed in our study. On the whole, both of these datasets are associated with several strengths and limita-
tions, and convergence of our and Northport findings is encouraging.
Finally, analysis of the most significant associations further revealed a presence of functional clusters, with 
SNPs on genes involved in particular neuronal functions/neurotransmitter pathways being more likely involved 
in phenotypes recorded in our sample than what would be expected by chance. All results are discussed in more 
detail below.
Functional clusters. Analysis of the 100 most significant associations among our candidate genes revealed 
an enrichment of genes involved in particular biological pathways within distinct behavioural domains. Within 
these top-scoring associations, there was an enrichment of loci on genes implicated in 5HT, Ach and glutamate 
regulation and activity/anxiety phenotypes. Also, SNPs associated with cognitive performance were located 
 nerve growth/death 5HT DA Ach GABA Glu other Adr
Anxiety/activity phenotypes 1 20 1 7 6 12 1 2
Cognitive phenotypes 4 4 0 1 12 1 2 3
Brain 0 6 1 3 8 2 0 0
Table 2.  Number of SNPs on genes involved in particular biological pathways (nerve growth/death; 
synaptic transmission: 5HT, DA, Ach, GABA, Glu, Adr, other) associated with different phenotypes 
(anxiety/activity phenotypes, cognitive phenotypes, brain) among the 100 most significant associations.
Figure 2. Summary of the findings for the top 5 SNP-phenotype association. The figure represents degree 
of significance, after controlling for family structure (FS) effects at q = 0.01 (**) or q = 0.05, gene expression 
detectable in the brain above the array median and correlation between expression levels and behaviour (dark 
grey for significant at p < 0.05; light grey for near-significant at p < 0.1).
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mainly on genes involved in GABAergic regulation. Finally, the majority of SNPs on genes involved in neuronal 
growth/death found in these top-scoring associations were involved in cognitive phenotypes (this last finding 
warrants caution due to very low numbers of SNPs in this group (5, out of which 4 were associated with cognitive 
measures). Extensive literature supports the biological plausibility of all of these SNP-phenotype clusters12–14, 
and these observations may reflect the underlying polygenicity of the traits we investigated. None of the SNP 
associations with brain measures remained significant after multiple testing correction (see the discussion below). 
However, clustering of the strongest associations with loci on GABA and 5HT genes – both involved in early 
neurodevelopment – warrants further investigation.
Genetic associations with behaviour. Sp2-elevated plus maze. The most significant SNP-behaviour 
association was between a SNP on Sp2 (rs3708840; missense mutation predicting threonine to isoleucine change, 
T166I) and an anxiety-related measure, time spent in the central area of the elevated plus maze test. In our sam-
ple, carriers of at least one minor allele spent significantly more time in the central area of the maze, an area 
thought to be associated with decision-making/avoidance of a potentially threatening environment15 - suggesting 
increased anxiety propensity in these individuals. Sp2 belongs to the family of specificity proteins (Sps) acting as 
transcription factors. The gene was shown to be crucial in early murine development16, affecting both cell prolif-
eration and differentiation17,18, but not much is known about its role in the context of behaviour. Our results from 
the expression analysis showed that the gene is brain-expressed in our sample, suggesting its role in behaviour 
is highly plausible. Nevertheless, we did not observe an association between its expression levels and behaviour, 
indicating that the gene’s polymorphism associated with anxiety phenotypes is likely to operate through altering 
properties of the protein, rather than any dose-dependent effects. Consistently with this explanation, in humans, 
SNPs in the SP2 region reside in the regulatory sequence (rs370243877, rs796052870), although the consequences 
of these polymorphisms are yet to be characterised.
Comparing our results with the Wellcome Trust data on Northport Stock HS mice provided further support 
for the importance of the Sp2 region in anxiety regulation. We found that a locus (ch11: 92,322,571–96,137,510) 
very close to Sp2 (ch11: 96,953,340–96,982,959) was associated with the distance travelled in the closed arms of 
the elevated plus maze in the Wellcome Trust resource. Although we did not examine this measure in our study, 
frequency of entry into closed arms in our stock was significantly correlated with time spent in the central area 
of the elevated plus maze test (the phenotype associated with Sp2). Furthermore, both the central zone and the 
closed arms are considered “protected areas” of the maze, therefore parameters recorded in these zones are likely 
regulated by the same behavioural components15. Therefore, it is possible that the measures associated with a QTL 
on chromosome 11 in our sample and Northport stock tap into the same phenotype, regulated by the Sp2 region 
in the mouse genome. Converging evidence from the association analyses in these two datasets, properties of the 
SNP analysed by us and brain expression of Sp2 all suggest that the gene can play an important role in anxiety 
regulation. Further verification of these effects could eventually be performed by analysing the knock-out phe-
notype, however, there is no data in the International Mouse Phenotyping Consortium database (IMPC; http://
www.mousephenotype.org/) at the time of writing this manuscript).
Tph1-light dark box. Two anxiety-related phenotypes measured in the light-dark exploration test showed signif-
icant association with a locus on Tph1 (rs262731280; missense mutation predicting tyrosine to cysteine change, 
Y206C), encoding tryptophan hydroxylase, a rate-limiting enzyme involved in 5HT synthesis. Minor allele car-
riers were more anxious, spending significantly less time in the light chamber, and making fewer transitions 
between light and dark chambers. Nevertheless, our findings warrant caution due to very low number of het-
erozygotes (n = 2), and lack of animals homozygous for the minor allele. Furthermore, the levels of expression 
were below the array median, and they did not associate with behaviour. Finally, analysis controlling for the 
relatedness in our sample suggested that the significant effects were likely driven by the family structure.
Indeed, the role of Tph1 in behaviour remains controversial. Traditionally it has been considered to be 
expressed primarily in the periphery19 and normal 5HT levels were recorded in brains of Tph1− /− mice19. 
However, some more recent evidence from rodents and humans suggests that the gene is expressed in the raphe 
nuclei20,21, although not as robustly as the Tph2 isoform. The Wellcome Trust HS resource does not contain meas-
ures from the light dark exploration test, and none of the regions reported to associate with elevated plus maze 
performance (also indexing anxiety) in Northport Stock were on chromosome 7, where Tph1 is located.
Htr3a – open field. The SNP in Htr3a investigated in our study (rs50670893) predicts a synonymous change in 
the protein-coding section of the gene. In our sample, carriers of the minor T allele displayed higher locomotor 
activity in the periphery of the open field arena, and this effect was strongest in the homozygous individuals. We 
also observed significant association between levels of Htr3a expression in the brain and behaviour – suggesting 
the mechanisms driving the SNP-phenotype association are likely expression related.
Htr3a (serotonin receptor 3 A) has an established role in behaviour regulation22, having been linked with harm 
avoidance23, schizophrenia24 (and its treatment response25) and anxiety disorders26–28, alongside other neuropsy-
chiatric traits (see review29). Although distance travelled in the outer zone of the open field is usually considered 
to index a locomotor activity rather than anxiety phenotype, given that the test is carried out in a novel arena, this 
measure likely also reflects the latter behavioural domain. In the Northport Stock Htr3a region was associated 
with activity in the open field (data for the outer zone alone is not available), with multiple additional association 
peaks in its wider genomic context on chromosome 9, validating our results from the Boulder stock. Similarly as 
for Sp2, the phenotypic consequences of Htr3a knock-out have not been described to date, although our results 
definitely warrant further interest in the role of Htr3a in behavioural regulation.
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Map2-puzzle box. Finally, a Map2 polymorphism we investigated was a non-synonymous mutation predict-
ing change from glycine to alanine (rs13475902, G987A), both small aliphatic amino acids. The polymorphism 
within the mRNA coding region could contribute to alterations in the gene expression, although, to the best of 
our knowledge, experimental evidence for the role of this SNP in this is still lacking.
In our sample the SNP was associated with latency to remove a plug in a puzzle box test, a problem-solving 
test (mice are required to complete consecutive puzzles, of which removal of the plug is the most difficult one). 
Carriers of the minor G allele spent significantly more time before successfully removing the plug, suggesting 
lower cognitive ability in these animals.
Although the association between expression levels and behaviour was just above our significance cut-off 
(p = 0.08), this suggests Map2 may be involved in the cognitive processes captured by the puzzle box test. Given 
that the gene is expressed ubiquitously in mouse brain (Fig. S6, Image credit: Allen Institute30), our expression 
analysis might have lacked spatial specificity to uncover the relationship between the expression levels and func-
tion. Individual mice with higher expression of the gene showed improved performance, as indexed by lower 
latency to remove the plug. These results are consistent with the literature, with previous studies showing a role 
of Map2 in cognitive performance in rats31,32, with reduced expression of the protein in individuals showing 
cognitive impairment. In humans, reduced expression was observed in hippocampi of schizophrenia patients33, 
a disorder that in rodents is, together with other tests, modelled using the puzzle box. Although we could not 
cross-validate our results in the Northport stock (due to the absence of cognitive measures for these individuals) 
nor in the IMPC knock-out resource (no phenotype available) previous evidence linking Map2 with cognitive 
function provides strong encouragement for further investigation of the role of this gene in behaviour.
Genetic associations with brain measures. None of the associations between our SNPs and brain meas-
ures remained significant after correcting for multiple testing. This does not imply the genetic variation we con-
sidered has no effect on brain function, as brain weights provide only fairly crude assessment of neural processes. 
Differences in connectivity patterns or synaptic efficiency, which could affect the behaviour in our sample, could 
not be assessed by the measures we took. Also, some structures that might have been crucial for the behaviours 
under analysis (e.g. amygdala in anxiety, frontal cortex in cognitive tests) were not included in the current study. 
Finally, although all brain dissections were carried out by the same individual, a degree of variation in the dissec-
tion procedure likely have remained.
Nevertheless, of note is the enrichment of SNPs involved in 5HT and GABA signalling among our top hits. 
Both of these neurotransmitters play prominent roles in early neurodevelopment, regulating processes like cell 
proliferation, neural outgrowth and apoptosis34,35. Interestingly, hippocampal weights were not correlated with 
body weight, unlike the total brain and cerebellar weights. Although this may result partly from the noise associ-
ated with the dissection, it has been suggested that hippocampal weight may be regulated by a unique set of genes 
compared to body weight36.
Genetic polymorphism in HS mice. There is a considerable scope for genetic variation in the HS stock, as 
revealed by our interrogation of the mouse SNP database published by the Wellcome Trust Sanger Consortium10, 
which includes information on over 65 million SNPs in 18 inbred strains. In the HS founders, there were 2,724 
SNPs annotated as exonic, with 317 (11.64%) out of them being highly polymorphic (allelic ratio of at least 4:6 in 
the founder/related strains – see the Online search section of Methods; due to divergence of certain lines used in 
the Boulder stock we looked at 10, rather than 8 strains). Given that there were altogether 553,545 polymorphic 
loci among these strains, using estimates from the exom presented above, one would expect 64,433 (11.64%) 
highly polymorphic SNPs of diverse genomic locations; this estimate will be affected by certain loci displaying 
preferential contribution of one of the founder strains37. This suggests that there is a large scope for maintaining 
genetic diversity in the HS over generations, even without taking into account de novo mutations that are likely to 
appear within the stock over time.
Although it is predicted that due to a genetic drift some of this variance will disappear over generations and 
alleles will become fixed in the population38, the rate of that has been shown to be relatively slow. Over > 50 gen-
erations in the Northport HS, 7.8% polymorphic alleles underwent fixation6. Those, however, probably included 
mainly the alleles that, although polymorphic, had low minor allele frequency, as fixation would act preferentially 
on those39. Eventually, highly polymorphic alleles would become fixed as well, but the time before that occurs is 
going to be substantially longer.
Nevertheless, some of the interrogated SNPs in our sample turned out to be out of HWE in our sample. This 
was not due to technical errors with the genotyping but due to our sample population as analysis by Mott and 
co-workers40 suggests that minor allele frequency in HS stocks is generally a limiting factor.
Limitations and future directions. Our study successfully uncovered several gene-behaviour associa-
tions, and demonstrated a significant enrichment in associations between distinct behavioural domains and loci 
on genes that were shown to be biologically relevant in these phenotypes. Nevertheless it must be borne in mind 
that all of the associations presented in this paper are statistical inferences, rather than experimental evidence of 
biology.
With regard to family structure, we used a design with a single offspring per pairing that, combined with the 
pseudorandom mating scheme largely avoided its effects. In practice, in a few cases up to 3 siblings from a litter 
were used, which could possibly inflate the strength of associations reported in our paper. We implemented the 
best available correction for this issue, including the family identity as a random effect in the model. 
We are also aware of the limitations stemming from the candidate gene approach, differences between genetic 
architecture in mice and humans, more extensive linkage disequilibrium in mice then humans41, as well as inher-
ently difficult translation of behavioural findings from mouse models to humans. Due to polygenicity of most 
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complex traits, most QTLs are likely to be of only very small phenotypic effect, and our study design had limited 
power to uncover such loci.
Finally, several methodological factors might have limited our scope in uncovering genetic associations with 
brain and behaviour measures in mice. A large number of hypotheses were tested, which is particularly problem-
atic in the context of low minor allele homozygotes at many of the investigated loci. In future research the latter 
problem could be addressed by mating the HS mice with inbreds homozygous for the minor allele at the SNP 
under investigation; such an approach would inflate the number of minor allele homozygotes, resulting in higher 
statistical power.
Materials and Methods
Animals. HS mice were obtained from the Institute of Behavioral Genetics (IBG) at the University of 
Colorado, Boulder (USA) and shipped to the UK at the age of 8 weeks. The mice were tested on a battery of 
behavioural tasks (see Table 3 and ref. 42) and culled aged 5 months. Given the large sample size, mice were 
tested in 9 batches of approximately 80–100 mice per batch. All animal work was licensed under the Animals 
(Scientific Procedures) Act 1986, reviewed and approved by the ethical review panel of the Institute of Psychiatry 
and the Home Office inspectorate, and was in accordance with the European Communities Council Directive of 
24 November 1986 (86/609/EEC). Project licence reference PPL 70/6342.
Sample collection and processing. Brain weights. At culling, brain samples were dissected and weighed, 
as described previously43. Briefly, immediately after cervical dissection, the whole brain (including olfactory bulbs 
and brainstem) was carefully removed from the skull. Whole brains were placed ventral side down on a sterile 
petri dish containing ice-cold artificial cerebrospinal fluid (aCSF: 124 mM NaCl, 3 mM KCl, 1.25 mM NaH2PO4, 
2 mM CaCl2.2H2O, 2 mM MgCl2.6H2O, Sigma, UK) over ice and dissected into a number of distinct brain regions. 
The brains were transected at the caudal margin of the cerebellum and the olfactory bulbs dissected out by cutting 
the fissura rhinalis using a scalpel blade. Wet cerebri (whole brain minus cerebellum and olfactory bulbs) were 
blotted on filter paper and immediately weighed to the nearest 0.1 mg. The right and left hippocampus and cere-
bellum were dissected on the petri dish over ice, blotted on filter paper and weighed. The following brain weights 
were collected: total wet brain weight, hippocampus (left and right combined) wet weight, and cerebellum wet 
weight.
DNA extraction and genotyping. DNA for genotyping was extracted from the spleen using a standard phenol/
chloroform protocol44. In some cases of an animal’s unexpected death, spleen samples were not available and 
DNA was extracted from a tail sample. Following the extraction, DNA was diluted 1/50 in Tris-EDTA buffer and 
stored at 4 °C. Genotyping was performed using primer extension methods (SNuPe for the in-house genotyping 
on the MegaBASE, and Amplifluor for KBiosciences genotyping).
RNA extraction and gene expression. RNA for expression analysis was extracted from cortex tissue using TRIzol 
reagent (Invitrogen, Paisley, UK). Data from 580 adult male HS mice (generations 66–72) was used for the asso-
ciation testing, with expression data available for 265 out of these. Briefly, brains were removed from the skull 
and placed dorsal side down on a wetted filter paper on a petri dish kept on ice. The cerebral halves were opened 
out from the midline, after cutting through the corpus callosum. Approximately 3 mm3 of tissue was cut from the 
anterior part of the frontal lobes (from bregma 2.46 mm to 1.34 mm45), mainly containing the medial prefron-
tal cortex including some prelimbic cortex, infralimbic cortex, cingulate cortex and motor cortex46. Expression 
profiles of the cortex tissue were determined using the Affymetrix GeneChip® Mouse Exon 1.0 ST Array (Santa 
Clara, CA, USA).
SNP selection. We investigated 126 SNPs within 78 candidate genes – see Table S1 for the full list; the loca-
tions of the SNPs were determined using Ensembl Mus musculus version 78.38 (GRCm38 p.3; http://www.ncbi.
nlm.nih.gov/projects/genome/assembly/grc/mouse/), and SNP rs numbers come from the dbSNP database 
(http://www.ncbi.nlm.nih.gov/projects/SNP/). In this SNP set we included loci involved in major neurotrans-
mitter pathways (66 genes, 114 SNPs), gene expression regulation (5 genes, 5 SNPs), and neuronal growth/death 
(7 genes, 7 SNPs). It was not feasible to comprehensively assess all loci with variation between the HS progenitor 
strains in this study so the approach taken was to test a number of SNPs from a range of candidate biological 
pathways. Out of all of our SNPs, 94 were in HWE, and all of these were used for the association analysis. The 
remaining ones were considered only if the Chi2 significance was just below the 0.05 cut-off value and there was 
a sufficient (> 3) number of minor allele homozygous animals. There were 10 of such SNPs, totalling 104 SNPs 
considered in our associations.
Behavioural battery. All mice were run through a test battery designed to assess locomotor activity, anxiety 
and cognitive phenotypes, as previously described42 (Table 3).
Statistical analysis. All analyses were conducted using the statistical software package R 2.15.2 (http://
www.r-project.com/). For all analysed SNPs it was verified whether these were in HWE using a Chi2-test. 
Normality of the distribution of the investigated phenotypes was assessed using the Shapiro-Wilk test, and visual 
inspection of relevant histograms.
Most phenotype variables were approximately normally distributed, and for all of these, a Box-Cox transfor-
mation was applied to ensure appropriateness of applying linear models in our association analyses (with linear 
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regression used for these analyses being nevertheless robust for data that mildly deviate from normality). Plots of 
the residuals (normality and residuals vs. observed values) were inspected to verify success of the transformation 
(Fig. S1). The only measures to which the Box-Cox transform was not applied were the ones that in our battery 
were found to have a censored distribution. These were mainly measures of latencies, as some animals did not 
perform the task in the allocated test time. These measures were analysed using the Cox proportional hazards 
model47. Morris Water Maze measures (DiffHidden1 and 5, Diffrev1 and 2, Inconsistency) representing differ-
ences between latencies to find the platform measured on different occasions were normally distributed, and these 
were analysed with a linear model after the Box-Cox transform.
Age and body weight at the time of killing were shown to have had a significant effect on brain weight with 
body weight having the largest effect, explaining approximately 17.4% of the variance in brain weight48. In our 
sample, these tended to cluster in batches, therefore analysis of variance tests were run to determine the effects 
of test batch on brain and behavioural phenotypes in our sample. Our results suggested that these effects were 
significant, therefore the batch (1–9) in which the animals arrived at the Centre was used as a categorical covariate 
in all association tests.
For genetic association analyses, correction for multiple testing was implemented using the Benjamini–
Hochberg step-up procedure for False Discovery Rate (FDR49 with cut-off values q = 0.05 and q = 0.01). Measures 
from each behavioural test were treated as a single hypothesis, due to the high correlation between them, as 
indicated by the Spearman test (chosen due to mild deviation from normality in pre-transformed data); the only 
exceptions were the Morris Water Maze measures, which were uncorrelated, and thus treated as separate hypoth-
eses. Each anatomical measure (body, whole brain, hippocampal and cerebellar weight) was also considered sep-
arately. Linkage disequilibrum (D’ ≥ 0.9) readouts were used in a hierarchical clustering analysis to compute the 
number of independent SNP groups. This highly conservative LD threshold produced 67 independent groups 
(only SNPs in HWE were considered; for the dendrogram of SNP clusters see Fig. S2). There were thus 871 tests 
performed (67 SNP clusters × 14 phenotypes). Association p-values from the tests run using Box-Cox transforms 
and survival analysis were pooled together for the FDR analysis, rather than considered as separate families; this 
was done because each SNP-phenotype association was considered under one model only. For all results we 
report the uncorrected p-value and the q threshold at which it was significant.
In our analyses we only considered an additive genetic model as it is the most parsimonious. Although we 
acknowledge that dominant or recessive models could be more appropriate for some SNP-phenotype associations, 
Test measure Description
Spontaneous activity in home cage - assessment of locomotion in a 
familiar (‘home’) environment, a baseline activity level
T1MSP Mean speed upon transfer to home cage 0–10 min (cm/sec)
TMSP Mean speed upon transfer to home cage 0–60 min (cm/sec)
HMSP Mean speed in home cage after habituation period 0–60 min (cm/sec)
Open field - measure of anxiety behaviour (avoidance of the central, 
open area)
OFD Time spent in the centre of the open field (sec)
OFA Peripheral activity: total distance travelled in the outer zone of the open field (cm)
OFBOLI Total boli deposited in the open field
Elevated plus maze - measure of anxiety behaviour (avoidance of 
the elevated, open arms)
P1OD Total duration on the open arm (sec)
P1CF Total entries into the closed arms
P1ND Total duration in the centre area (sec)
Light/dark exploration test - measure of anxiety behaviour 
(avoidance of the light chamber)
LDT Number of transitions between light and dark chambers
LDLD Time spent in the light chamber (sec)
LDDA Total distance travelled in the dark chamber (sec)
Novel object exploration in the open field - animal’s response 
towards the novel object placed in the open field NOD Total time spent exploring the novel object (sec)
Puzzle box - measure of animal’s problem solving skills. 
Training Time taken by the mouse to crawl through an underpass to enter the goal box on 2 consecutive occasions (sec)
Burrow Time taken by the mouse to burrow through the underpass obscured with sawdust (sec)
Plug Time taken by the mouse to remove a cardboard plug blocking the underpass (sec)
Morris water maze – assessment of spatial learning and memory. 
Learning in the test is indicated by decreasing latencies to find the 
hidden platform on repeated exposure to the maze on consecutive 
days.
DiffHidden1and5 The difference between the mean latency taken to find the platform on day 1 and 5 (sec)
Diffrev1and2
The difference between the latency taken to find the platform in the 
second reversal task, minus the latency to find the platform in the first 
reversal task; during the reversal task the location of the platform was 
changed, so that the animal had to learn the new location. This measure 
reflects an animal’s cognitive flexibility (sec)
Inconsistency
Mean difference between latencies (sums from all trials in a given session) 
on subsequent days (e.g. D1 and D2 morning) and at different times in a 
given day (e.g. D1 morning vs afternoon)
Nesting – animal’s propensity towards building nests  
(shelter/reproductive purposes) 
Nest1 Nest weight on day 1 (g)
Nest2 Nest weight on day 2 (g)
Table 3.  Behavioural measures in the locomotor activity, exploration, anxiety and cognitive battery used 
for association testing in HS mice. Tests were run according to the protocols specified by Lad et al.42.
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we currently have no biological grounds to think this could be the case, and considering these alternatives as well 
would further multiply the number of tests performed.
For the SNP-phenotype associations that remained significant after controlling for multiple testing, the 
distribution of residuals was further examined (visual inspection of histograms and qq plots) to ensure no 
unaccounted-for effects were driving the highly-significant p-values. Furthermore, in order to verify these results 
did not arise solely due to family structure present in the data, we used mixed models estimated using maxi-
mum likelihood procedure to analyse the top SNP-phenotype associations, entering family ID as a random effect 
around the intercept (package lme4). Total number of SNP-phenotype pairs investigated at this stage was used in 
the FDR procedure.
A hundred of the most significant SNP-phenotype associations were further examined for the possibility 
of existence of functional clusters. After cross-tabulating the results, an omnibus Chi2 test was used to analyse 
the association between genes involved in particular biological pathways (5HT, DA, Ach, Glu, GABA, adrener-
gic, neuron growth/death, other) and behavioural domains (anxiety, activity and cognitive phenotypes) or brain 
measures.
Gene expression analysis was carried out using the oligo Bioconductor package50 focusing on the genes signif-
icantly associated with the phenotypic measures. Raw cel files for 265 samples were read into R and background 
corrected as well as normalized using the Robust Multi-array Average (rma) algorithm. Signal intensities were 
summarised at the transcript level. We checked whether the genes were expressed in the mouse cortex samples, 
using the median expression of all transcripts as a cut-off. Subsequently, association-tests between gene expres-
sion and behavioural outcomes were run using linear models. Given expression analyses was performed only on 
the SNP-phenotype pairs that remained significant in the genetic association testing after the FDR correction, no 
multiple testing correction was applied to these results, therefore only uncorrected p-values are reported.
Online search. In order to integrate our work with the currently existing mouse genomic resources, we ver-
ified all our results in the Northport HS stock through an online resource created by the Wellcome Trust Centre 
for Human Genetics (http://mus.well.ox.ac.uk/mouse/HS/)11. The tool allows investigation of QTLs for a number 
of physiological and behavioural traits in mice. Given that the Northport and Boulder heterogeneous stocks only 
had partially overlapping founders, the results from these two lines are not directly comparable, however, their 
convergence limits the possibility that a significant genotype-phenotype association is just a statistical artefact. 
We restricted the search to 10 Mbp upstream and downstream of the variant identified in our analyses. Given the 
sets of phenotypes available for our sample and Northport stock differed somewhat, for all the non-overlapping 
ones we identified another, best corresponding phenotype in the Wellcome Trust resource.
Furthermore, we explored the genetic variation among the inbred lines used as Boulder stock founders, using 
results of the Mouse Genome Project (http://www.sanger.ac.uk/science/data/mouse-genomes-project). Where 
further distinctions in strain nomenclature were introduced since when Boulder HS stock was started, we used 
the most closely related one, with our final choices being: A/J, AKR/J, BALB/cJ, C3H/HeJ, C56BL/6J, C57BL/10J, 
DBA/2J, I/LnJ, IS/CamRkJ, RIIIS/J (NB we looked at ten, rather than eight inbred strains, reflecting divergence 
of certain lines used in the Boulder stock). We looked at the number of SNPs in these strains, the proportion of 
exonic ones, and how many of them were likely polymorphic in the Boulder HS stock (which we defined as allelic 
ratio of at least 4:6 in the founders).
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